Quest Diagnostics DGX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $393M+109% | $420M-23.5% | $432M-43.5% | $319M+17.7% | $188M-60.3% | ||
| $1.59B+13.0% | $1.41B+8.0% | $1.46B+5.8% | $1.42B+7.6% | $1.4B+6.2% | ||
| $225M+19.0% | $189M+0.5% | $186M+1.1% | $187M+2.7% | $189M+4.4% | ||
| $361M+22.8% | $361M+2.8% | $333M+11.4% | $273M+11.4% | $294M+17.1% | ||
| $2.57B+23.7% | $2.38B-0.6% | $2.41B-8.2% | $2.2B+9.0% | $2.08B-6.9% | ||
| $2.19B+4.3% | $2.2B+4.3% | $2.15B+2.5% | $2.12B+15.7% | $2.1B+15.9% | ||
| $691M+5.3% | $657M+0.9% | $649M-1.8% | $655M+8.6% | $656M+13.3% | ||
| $9.12B+3.1% | $8.95B+1.0% | $8.9B+3.4% | $8.88B+12.7% | $8.85B+13.0% | ||
| $1.72B-0.5% | $1.64B-7.2% | $1.66B-3.1% | $1.71B+41.9% | $1.73B+44.7% | ||
| $256M-1.5% | $270M+5.9% | $296M+8.8% | $271M+25.5% | $260M+42.9% | ||
| $134M0.0% | $136M+10.6% | $137M+9.6% | $136M+7.9% | $134M+0.8% | ||
| $16.67B+5.5% | $16.23B+0.4% | $16.2B+0.6% | $15.97B+15.0% | $15.8B+13.2% | ||
| $1.5B+18.4% | $1.6B+14.8% | $1.46B+11.0% | $1.35B+8.2% | $1.27B+2.3% | ||
| $503M+50,200% | $504M-16.3% | $504M-16.4% | $504M-16.8% | $1M-99.9% | ||
| $174M+0.6% | $174M+0.6% | $173M-1.7% | $171M+7.5% | $173M+13.1% | ||
| $2.18B+51.1% | $2.28B+5.0% | $2.13B+2.0% | $2.02B+0.6% | $1.44B-37.3% | ||
| $5.16B-12.0% | $5.17B-8.0% | $5.17B-8.4% | $5.17B+35.5% | $5.86B+54.0% | ||
| $574M+6.7% | $537M+0.4% | $534M-1.7% | $540M+6.5% | $538M+10.0% | ||
| $1.02B+11.5% | $957M+2.0% | $982M+10.2% | $890M+9.7% | $917M+12.2% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $2.35B+1.6% | $2.38B+0.8% | $2.36B+1.0% | $2.33B+0.8% | $2.31B+0.8% | ||
| $10.15B+7.0% | $9.99B+6.8% | $9.84B+6.7% | $9.68B+6.6% | $9.49B+6.2% | ||
| -$43M+48.2% | -$27M+69.3% | -$40M-167% | -$16M+15.8% | -$83M-419% | ||
| $5.09B+6.3% | $5.18B+6.7% | $4.9B+3.5% | $4.77B+0.3% | $4.79B+0.2% | ||
| $79M-2.5% | $80M-3.6% | $81M+1.3% | $81M+2.5% | $81M+5.2% | ||
| $300M+809% | $36M+2.9% | $37M+15.6% | $37M-5.1% | $33M-10.8% | ||
| $7.37B+6.3% | $7.17B+5.8% | $7.26B+6.6% | $7.23B+9.2% | $6.93B+7.7% | ||
| $16.67B+5.5% | $16.23B+0.4% | $16.2B+0.6% | $15.97B+15.0% | $15.8B+13.2% | ||
| $256M-1.5% | $270M+5.9% | $296M+8.8% | $271M+25.5% | $260M+42.9% | ||
| $691M+5.3% | $657M+0.9% | $649M-1.8% | $655M+8.6% | $656M+13.3% | ||
| $1.72B-0.5% | $1.64B-7.2% | $1.66B-3.1% | $1.71B+41.9% | $1.73B+44.7% | ||
| $691M+5.3% | $657M+0.9% | $649M-1.8% | $655M+8.6% | $656M+13.3% | ||
| $256M-1.5% | $270M+5.9% | $296M+8.8% | $271M+25.5% | $260M+42.9% | ||
| $691M+5.3% | $657M+0.9% | $649M-1.8% | $655M+8.6% | $656M+13.3% | ||
| $256M-1.5% | $270M+5.9% | $296M+8.8% | $271M+25.5% | $260M+42.9% | ||
| $1.5B+18.4% | $1.6B+14.8% | $1.46B+11.0% | $1.35B+8.2% | $1.27B+2.3% | ||
| $5.16B-12.0% | $5.17B-8.0% | $5.17B-8.4% | $5.17B+35.5% | $5.86B+54.0% | ||
| $2.35B+1.6% | $2.38B+0.8% | $2.36B+1.0% | $2.33B+0.8% | $2.31B+0.8% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $5.09B+6.3% | $5.18B+6.7% | $4.9B+3.5% | $4.77B+0.3% | $4.79B+0.2% | ||
| $134M0.0% | $136M+10.6% | $137M+9.6% | $136M+7.9% | $134M+0.8% | ||
| $5.16B-12.0% | $5.17B-8.0% | $5.17B-8.4% | $5.17B+35.5% | $5.86B+54.0% | ||
| $300M+809% | $36M+2.9% | $37M+15.6% | $37M-5.1% | $33M-10.8% | ||
| $79M-2.5% | $80M-3.6% | $81M+1.3% | $81M+2.5% | $81M+5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Quest Diagnostics's total assets?
- Quest Diagnostics (DGX) holds $16.7B in total assets, up 5.5% year over year.
- How much debt does Quest Diagnostics have?
- Quest Diagnostics carries $6.4B in total debt against $7.4B of shareholders' equity, a debt-to-equity ratio of 0.87.
- How much cash does Quest Diagnostics have?
- Quest Diagnostics holds $393.0M in cash and equivalents.
- Can Quest Diagnostics cover its short-term obligations?
- Its current ratio is 1.18 — current assets exceed current liabilities.
- Where does Quest Diagnostics's balance sheet data come from?
- Every line is extracted from Quest Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
